Medicure Inc. MCUJF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 39.57% | 45.43% | 29.43% | 21.11% | 7.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.57% | 45.43% | 29.43% | 21.11% | 7.61% |
| Cost of Revenue | 92.82% | 102.77% | 90.65% | 40.33% | 21.06% |
| Gross Profit | -3.76% | 1.73% | -11.88% | 5.80% | -1.31% |
| SG&A Expenses | 28.27% | 25.46% | 19.30% | -2.04% | -2.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.00% | 53.59% | 42.60% | 12.57% | 5.95% |
| Operating Income | -166.34% | -109.28% | -147.50% | 31.31% | 6.27% |
| Income Before Tax | -557.65% | -342.02% | -778.72% | -59.04% | 57.09% |
| Income Tax Expenses | -18.35% | -31.55% | -19.53% | 187.07% | 120.85% |
| Earnings from Continuing Operations | -466.29% | -286.43% | -580.88% | -65.03% | 50.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -466.29% | -286.43% | -580.88% | -65.03% | 50.79% |
| EBIT | -166.34% | -109.28% | -147.50% | 31.31% | 6.27% |
| EBITDA | -545.43% | -247.75% | -372.64% | 58.45% | 27.37% |
| EPS Basic | -466.63% | -286.51% | -580.47% | -65.06% | 50.81% |
| Normalized Basic EPS | -168.22% | -113.60% | -156.55% | 30.93% | 4.85% |
| EPS Diluted | -435.16% | -274.57% | -565.50% | -66.28% | 48.32% |
| Normalized Diluted EPS | -168.68% | -113.91% | -156.38% | 31.04% | 5.24% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | -0.14% | -0.14% | 0.00% | 0.00% | -2.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |